Postoperative Pain and Skin Closure Methods After Cesarean Section (Skin)

October 20, 2017 updated by: Wake Forest University Health Sciences

Post-Operative Pain and Skin Closure Methods After Cesarean Section

The study is looking at women undergoing cesarean section delivery of their baby. The purpose of this research study is to determine what type of skin closure after cesarean section helps decrease pain level the most and improves the appearance of the incision site.

The study hypothesis is to determine if skin closure with absorbable subcuticular staples leads to improved cosmesis and/or decreased post-operative pain.

Participants in the study will already be scheduled for a cesarean section for delivery of their baby. They will be randomized into one of three groups, 1) Insorb (absorbable subcuticular stapes), 2) Vicryl suture or 3) Monocryl suture for the skin closure of their cesarean section. Information that will be recorded includes amount of pain medication usage while in the hospital after cesarean section, daily patient rated pain score until discharge from hospital, pain score 6 weeks after surgery and cesarean section cosmetic scar 6 weeks after surgery.

Study Overview

Detailed Description

Cesarean delivery is the most common surgical procedure performed in the United States, with over 1 million procedures performed per year. Based on recent Centers for Disease Control National Vital Statistics Report 32.3% of all births in the United States were via cesarean delivery, marking the twelfth consecutive annual increase in the cesarean delivery rate. Given the high numbers of cesarean deliveries being performed today, there has been interest in optimizing surgical techniques. Several recent reviews have summarized the evidence for various steps of cesarean delivery, but surprisingly in many cases there is little scientific evidence on which to base the choice of surgical technique.

The topic of skin closure after cesarean delivery is an area that has been the focus of several randomized control trials. The trials compared surgical steel staples to subcuticular suture of various materials focusing on differences in post-operative pain, infection rates, and scar cosmesis. Cosmesis has been investigated in all three Randomized Clinical Trials and none have found differences between surgical steel staples and subcuticular suture. Infection rate has been studied in a single observational study which found a higher infection rate in those patients whose skin was closed with surgical steel staples compared to suture. Studies of post-operative pain and skin closure technique have been contradictory. The earliest Randomized clinical trial to investigate skin closure and post-operative pain was done by Frishman et al (5) and found that subjective self-assessment of pain was better at hospital discharge and 6 weeks post-operatively in patients when subcuticular suture rather than surgical steel staples were used. A subsequent Randomized clinical trial reported the opposite result with less pain 6 weeks post-operatively when surgical steel staples were used. This discrepancy may, in part, be due to the different suture material used in the two trials. The study by Frishman et al which showed a benefit of subcuticular suture utilized used polyglycolic acid (Vicryl suture or Insorb staples); whereas, the study by Rousseau et al used polyglecaprone (Monocryl suture). To date direct comparison of skin closure at the time of cesarean with these two suture materials has not been performed.

Recently, a new technology for skin closure has been introduced that employs absorbable material, polylactic and polyglycolic acid, in subcuticular staples. In animal models this method of skin closure has shown less histological inflammation and fewer wound infections than either surgical steel staples or subcuticular suture. Unfortunately, little is known about how this skin closure technique compares to the other more established techniques after cesarean delivery in humans. However, a retrospective analysis comparing subcuticular absorbable staples with surgical steel staples revealed an association between subcuticular absorbable staples and decreased in-hospital analgesic use. The current study is a prospective randomized trial that investigates four cesarean skin closure techniques-surgical steel staples, subcuticular polyglycolic acid suture (Vicryl), subcuticular, polyglecaprone suture (Monocryl), and absorbable subcuticular polyglycolic acid staples-to determine if one is associated with improved cosmesis or a decrease in post-operative pain.

Study Type

Interventional

Enrollment (Actual)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • North Carolina
      • Winston-Salem, North Carolina, United States, 27103
        • Forsyth Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 44 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Age 18-44
  • Any race
  • Any parity
  • Scheduled Cesarean Section
  • Neuraxial analgesia

Exclusion Criteria:

  • Diabetes Mellitus
  • Maternal Connective Tissue Disorder
  • Maternal Steroid Use

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: INSORB staples skin closure
Women undergoing cesarean section delivery will have skin closure with INSORB staples.
Patients will be randomized to Monocryl skin closure and compared to Insorb skin closure and Vicryl skin closure.
Patients will be randomized to Vicryl skin closure and compared to Insorb and Monocryl skin closure groups.
Active Comparator: Monocryl skin closure
Women undergoing cesarean section delivery will have skin closure with Monocryl.
Patients will be randomized to Vicryl skin closure and compared to Insorb and Monocryl skin closure groups.
Patients will be randomized to Insorb staples skin closure and compared to Monocryl and Vicryl group.
Active Comparator: Vicryl skin closure
Women undergoing cesarean section delivery will have Vicryl skin closure
Patients will be randomized to Monocryl skin closure and compared to Insorb skin closure and Vicryl skin closure.
Patients will be randomized to Insorb staples skin closure and compared to Monocryl and Vicryl group.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intravenous and analgesic use.
Time Frame: Admission for delivery of baby by cesarean section to expected postpartum average of 6 weeks
Record the amount of in hospital intravenous and oral analgesic use.
Admission for delivery of baby by cesarean section to expected postpartum average of 6 weeks
Daily subjective pain score while hospitalized
Time Frame: Hospital admission for cesarean section delivery
Daily patient rated subjective pain score (0-10 based on visual analog scale) until dismissal from the hospital will be recorded.
Hospital admission for cesarean section delivery
6 week postoperative subjective pain score
Time Frame: After cesarean section delivery at the 6 week postpartum visit
Patient rated subjective pain score 6 weeks postoperatively will be recorded.
After cesarean section delivery at the 6 week postpartum visit
Scar cosmetic score 6 weeks post-operatively.
Time Frame: 6 weeks post-operatively after cesarean section
6 weeks post-operative scar cosmetic score will be recorded.
6 weeks post-operatively after cesarean section

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Wound complications
Time Frame: Time of cesarean section until 6 weeks postpartum visit
Wound complications (infection, separation, or seroma)
Time of cesarean section until 6 weeks postpartum visit
Length of hospital stay
Time Frame: C/S admission to discharge time
Length of hospital stay
C/S admission to discharge time

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Joshua Nitsche, MD, PhD, Wake Forest Baptist School of Medicine

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2012

Primary Completion (Actual)

January 1, 2016

Study Completion (Actual)

January 1, 2016

Study Registration Dates

First Submitted

October 9, 2012

First Submitted That Met QC Criteria

January 2, 2014

First Posted (Estimate)

January 6, 2014

Study Record Updates

Last Update Posted (Actual)

October 24, 2017

Last Update Submitted That Met QC Criteria

October 20, 2017

Last Verified

October 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • 17928

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pregnancy

Clinical Trials on Monocryl skin closure

Subscribe